Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.
Journal: 2006/February - Microbiology and Molecular Biology Reviews
ISSN: 1092-2172
Abstract:
Coronaviruses are a family of enveloped, single-stranded, positive-strand RNA viruses classified within the Nidovirales order. This coronavirus family consists of pathogens of many animal species and of humans, including the recently isolated severe acute respiratory syndrome coronavirus (SARS-CoV). This review is divided into two main parts; the first concerns the animal coronaviruses and their pathogenesis, with an emphasis on the functions of individual viral genes, and the second discusses the newly described human emerging pathogen, SARS-CoV. The coronavirus part covers (i) a description of a group of coronaviruses and the diseases they cause, including the prototype coronavirus, murine hepatitis virus, which is one of the recognized animal models for multiple sclerosis, as well as viruses of veterinary importance that infect the pig, chicken, and cat and a summary of the human viruses; (ii) a short summary of the replication cycle of coronaviruses in cell culture; (iii) the development and application of reverse genetics systems; and (iv) the roles of individual coronavirus proteins in replication and pathogenesis. The SARS-CoV part covers the pathogenesis of SARS, the developing animal models for infection, and the progress in vaccine development and antiviral therapies. The data gathered on the animal coronaviruses continue to be helpful in understanding SARS-CoV.
Relations:
Content
Citations
(254)
References
(370)
Diseases
(3)
Chemicals
(2)
Organisms
(7)
Anatomy
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Microbiol Mol Biol Rev 69(4): 635-664

Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus

Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, Department of Microbiology and Immunology, Center for Molecular Medicine and Infectious Disease, Drexel College of Medicine, Philadelphia, Pennsylvania2
Corresponding author. Mailing address for Susan R. Weiss: Department of Microbiology, University of Pennsylvania School of Medicine, 36th Street and Hamilton Walk, Philadelphia, PA 19104-6076. Phone: (215) 898-8013. Fax: (215) 573-4858. E-mail: ude.nnepu.dem.liam@rsssiew. Mailing address for Sonia Navas-Martin: Department of Microbiology and Immunology, Institute for Molecular Medicine and Infectious Disease, Drexel College of Medicine, 245 N. 15th Street, Philadelphia, PA 19102. Phone: (215) 762-7284. Fax: (215) 848-2271. E-mail: s.navas-martin@drexel.edu.

Abstract

Coronaviruses are a family of enveloped, single-stranded, positive-strand RNA viruses classified within the Nidovirales order. This coronavirus family consists of pathogens of many animal species and of humans, including the recently isolated severe acute respiratory syndrome coronavirus (SARS-CoV). This review is divided into two main parts; the first concerns the animal coronaviruses and their pathogenesis, with an emphasis on the functions of individual viral genes, and the second discusses the newly described human emerging pathogen, SARS-CoV. The coronavirus part covers (i) a description of a group of coronaviruses and the diseases they cause, including the prototype coronavirus, murine hepatitis virus, which is one of the recognized animal models for multiple sclerosis, as well as viruses of veterinary importance that infect the pig, chicken, and cat and a summary of the human viruses; (ii) a short summary of the replication cycle of coronaviruses in cell culture; (iii) the development and application of reverse genetics systems; and (iv) the roles of individual coronavirus proteins in replication and pathogenesis. The SARS-CoV part covers the pathogenesis of SARS, the developing animal models for infection, and the progress in vaccine development and antiviral therapies. The data gathered on the animal coronaviruses continue to be helpful in understanding SARS-CoV.

Abstract

Acknowledgments

We are indebted to many colleagues for helpful discussions and thoughts. We apologize to any investigators whose work we have inadvertently omitted.

We acknowledge NIH grants AI17418, AI60021 (formerly NS21954), NS30606, and AI47800, as well as grant RG2585B5 from the National Multiple Sclerosis Society, to S.R.W. S.N.-M. is funded by Drexel College of Medicine.

Acknowledgments

REFERENCES

REFERENCES

References

  • 1. Addie, DD. 2004. Feline coronavirus—that enigmatic little critter. Vet. J.167:5-6. [[PubMed][Google Scholar]
  • 2. Almazan, F., J. M. Gonzalez, Z. Penzes, A. Izeta, E. Calvo, J. Plana-Duran, and L. Enjuanes. 2000. Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. USA97:5516-5521.
  • 3. An, S., C. J. Chen, X. Yu, J. L. Leibowitz, and S. Makino. 1999. Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J. Virol.73:7853-7859.
  • 4. Anton, I. M., C. Sune, R. H. Meloen, F. Borras-Cuesta, and L. Enjuanes. 1995. A transmissible gastroenteritis coronavirus nucleoprotein epitope elicits T helper cells that collaborate in the in vitro antibody synthesis to the three major structural viral proteins. Virology212:746-751. [[PubMed]
  • 5. Arden, K. E., M. D. Nissen, T. P. Sloots, and I. M. Mackay. 2005. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J. Med. Virol.75:455-462. [[PubMed]
  • 6. Ashraf, H. 2003. WHO declares Beijing to be free of SARS. Lancet361:2212. [[PubMed]
  • 7. Bailey, O. T., A. M. Pappenheimer, F. Sargent, M. D. Cheever, and J. B. Daniels. 1949. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. II. Pathology. J. Exp. Med.90:195-212.
  • 8. Baric, R. S., E. Sullivan, L. Hensley, B. Yount, and W. Chen. 1999. Persistent infection promotes cross-species transmissibility of mouse hepatitis virus. J. Virol.73:638-649.
  • 9. Barnard, D. L., V. D. Hubbard, J. Burton, D. F. Smee, J. D. Morrey, M. J. Otto, and R. W. Sidwell. 2004. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-d-N4-hydroxycytidine. Antiviral Chem. Chemother.15:15-22. [[PubMed]
  • 10. Barthold, S. W., D. S. Beck, and A. L. Smith. 1993. Enterotropic coronavirus (mouse hepatitis virus) in mice: influence of host age and strain on infection and disease. Lab. Anim. Sci.43:276-284. [[PubMed]
  • 11. Basler, C. F., X. Wang, E. Muhlberger, V. Volchkov, J. Paragas, H. D. Klenk, A. Garcia-Sastre, and P. Palese. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA97:12289-12294.
  • 12. Bastien, N., K. Anderson, L. Hart, P. Van Caeseele, K. Brandt, D. Milley, T. Hatchette, E. C. Weiss, and Y. Li. 2005. Human coronavirus NL63 infection in Canada. J. Infect. Dis.191:503-506. [[PubMed]
  • 13. Beauchemin, N., P. Draber, G. Dveksler, P. Gold, S. Gray-Owen, F. Grunert, S. Hammarstrom, K. V. Holmes, A. Karlsson, M. Kuroki, S. H. Lin, L. Lucka, S. M. Najjar, M. Neumaier, B. Obrink, J. E. Shively, K. M. Skubitz, C. P. Stanners, P. Thomas, J. A. Thompson, M. Virji, S. von Kleist, C. Wagener, S. Watt, and W. Zimmermann. 1999. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell Res.252:243-249. [[PubMed]
  • 14. Belay, E. D., D. D. Erdman, L. J. Anderson, T. C. Peret, S. J. Schrag, B. S. Fields, J. C. Burns, and L. B. Schonberger. 2005. Kawasaki disease and human coronavirus. J. Infect. Dis.192:352-353. [[PubMed]
  • 15. Bergmann, C., M. McMillan, and S. Stohlman. 1993. Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein. J. Virol.67:7041-7049.
  • 16. Bisht, H., A. Roberts, L. Vogel, A. Bukreyev, P. L. Collins, B. R. Murphy, K. Subbarao, and B. Moss. 2004. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc. Natl. Acad. Sci. USA101:6641-6646.
  • 17. Bonavia, A., B. D. Zelus, D. E. Wentworth, P. J. Talbot, and K. V. Holmes. 2003. Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J. Virol.77:2530-2538.
  • 18. Bond, C. W., J. L. Leibowitz, and J. A. Robb. 1979. Pathogenic murine coronaviruses. II. Characterization of virus-specific proteins of murine coronaviruses JHMV and A59V. Virology94:371-384. [[PubMed]
  • 19. Booth, C. M., L. M. Matukas, G. A. Tomlinson, A. R. Rachlis, D. B. Rose, H. A. Dwosh, S. L. Walmsley, T. Mazzulli, M. Avendano, P. Derkach, I. E. Ephtimios, I. Kitai, B. D. Mederski, S. B. Shadowitz, W. L. Gold, L. A. Hawryluck, E. Rea, J. S. Chenkin, D. W. Cescon, S. M. Poutanen, and A. S. Detsky. 2003. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA289:2801-2809. [[PubMed]
  • 20. Boots, A. M., J. G. Kusters, J. M. van Noort, K. A. Zwaagstra, E. Rijke, B. A. van der Zeijst, and E. J. Hensen. 1991. Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology74:8-13.
  • 21. Bosch, B. J., C. A. de Haan, and P. J. Rottier. 2004. Coronavirus spike glycoprotein, extended at the carboxy terminus with green fluorescent protein, is assembly competent. J. Virol.78:7369-7378.
  • 22. Bosch, B. J., B. E. Martina, R. Van Der Zee, J. Lepault, B. J. Haijema, C. Versluis, A. J. Heck, R. De Groot, A. D. Osterhaus, and P. J. Rottier. 2004. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc. Natl. Acad. Sci. USA101:8455-8460.
  • 23. Bosch, B. J., R. van der Zee, C. A. de Haan, and P. J. Rottier. 2003. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol.77:8801-8811.
  • 24. Bray, M., K. Davis, T. Geisbert, C. Schmaljohn, and J. Huggins. 1998. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis.178:651-661. [[PubMed]
  • 25. Bredenbeek, P. J., C. J. Pachuk, A. F. Noten, J. Charite, W. Luytjes, S. R. Weiss, and W. J. Spaan. 1990. The primary structure and expression of the second open reading frame of the polymerase gene of the coronavirus MHV-A59; a highly conserved polymerase is expressed by an efficient ribosomal frameshifting mechanism. Nucleic Acids Res.18:1825-1832.
  • 26. Brian, DA. 2001. Nidovirus genome replication and subgenomic mRNA synthesis. Pathways followed and cis-acting elements required. Adv. Exp. Med. Biol.494:415-428. [[PubMed][Google Scholar]
  • 27. Brian, D. A., and R. S. Baric. 2005. Coronavirus genome structure and replication. Curr. Top. Microbiol. Immunol.287:1-30. [[PubMed]
  • 28. Brian, D. A., B. G. Hogue, and T. E. Kienzle. 1995. The coronavirus hemagglutinin esterase glycoprotein, p. 165-179. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
  • 29. Brown, E. G., H. Liu, L. C. Kit, S. Baird, and M. Nesrallah. 2001. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl. Acad. Sci. USA98:6883-6888.
  • 30. Buchholz, U. J., A. Bukreyev, L. Yang, E. W. Lamirande, B. R. Murphy, K. Subbarao, and P. L. Collins. 2004. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc. Natl. Acad. Sci. USA101:9804-9809.
  • 31. Buer, J., and RBalling. 2003. Mice, microbes and models of infection. Nat Rev. Genet.4:195-205. [[PubMed][Google Scholar]
  • 32. Bukreyev, A., E. W. Lamirande, U. J. Buchholz, L. N. Vogel, W. R. Elkins, M. St Claire, B. R. Murphy, K. Subbarao, and P. L. Collins. 2004. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet363:2122-2127. [[PubMed]
  • 33. Burks, J. S., B. L. DeVald, L. D. Jankovsky, and J. Gerdes. 1980. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science209:933-934. [[PubMed]
  • 34. Casais, R., M. Davies, D. Cavanagh, and P. Britton. 2005. Gene 5 of the avian coronavirus infectious bronchitis virus is not essential for replication. J. Virol.79:8065-8078.
  • 35. Casais, R., B. Dove, D. Cavanagh, and P. Britton. 2003. Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism. J. Virol.77:9084-9089.
  • 36. Casais, R., V. Thiel, S. G. Siddell, D. Cavanagh, and P. Britton. 2001. Reverse genetics system for the avian coronavirus infectious bronchitis virus. J. Virol.75:12359-12369.
  • 37. Cavanagh, D. 2003. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol.32:567-582. [[PubMed]
  • 38. Cavanagh, D., K. Mawditt, B. Welchman Dde, P. Britton, and R. E. Gough. 2002. Coronaviruses from pheasants (Phasianus colchicus) are genetically closely related to coronaviruses of domestic fowl (infectious bronchitis virus) and turkeys. Avian Pathol.31:81-93. [[PubMed]
  • 39. Chang, K. W., Y. Sheng, and J. L. Gombold. 2000. Coronavirus-induced membrane fusion requires the cysteine-rich domain in the spike protein. Virology269:212-224. [[PubMed]
  • 40. Chang, Y. J., C. Y. Liu, B. L. Chiang, Y. C. Chao, and C. C. Chen. 2004. Induction of IL-8 release in lung cells via activator protein-1 by recombinant baculovirus displaying severe acute respiratory syndrome-coronavirus spike proteins: identification of two functional regions. J. Immunol.173:7602-7614. [[PubMed]
  • 41. Cheever, F. S., J. B. Daniels, A. M. Pappenheimer, and O. T. Baily. 1949. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. I. Isolation and biological properties of the virus. J. Exp. Med.90:181-194.
  • 42. Chen, C. J., K. Sugiyama, H. Kubo, C. Huang, and S. Makino. 2004. Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase. J. Virol.78:10410-10419.
  • 43. Chen, D. S., M. Asanaka, F. S. Chen, J. E. Shively, and M. M. Lai. 1997. Human carcinoembryonic antigen and biliary glycoprotein can serve as mouse hepatitis virus receptors. J. Virol.71:1688-1691.
  • 44. Chen, D. S., M. Asanaka, K. Yokomori, F.-I. Wang, S. B. Hwang, H.-P. Li, and M. M. C. Lai. 1995. Pregnancy-specific glycoprotein is expressed in the brain and serves as receptor for mouse hepatitis virus. Proc. Natl. Acad. Sci. USA92:12095-12099.
  • 45. Chen, F., K. H. Chan, Y. Jiang, R. Y. Kao, H. T. Lu, K. W. Fan, V. C. Cheng, W. H. Tsui, I. F. Hung, T. S. Lee, Y. Guan, J. S. Peiris, and K. Y. Yuen. 2004. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol.31:69-75. [[PubMed]
  • 46. Chen, W., B. Yount, L. Hensley, and R. S. Baric. 1998. Receptor homologue scanning functions in the maintenance of MHV-A59 persistence in vitro. Adv. Exp. Med. Biol.440:743-750. [[PubMed]
  • 47. Chen, Y. Y., B. Shuang, Y. X. Tan, M. J. Meng, P. Han, X. N. Mo, Q. S. Song, X. Y. Qiu, X. Luo, Q. N. Gan, X. Zhang, Y. Zheng, S. A. Liu, X. N. Wang, N. S. Zhong, and D. L. Ma. 2005. The protein X4 of severe acute respiratory syndrome-associated coronavirus is expressed on both virus-infected cells and lung tissue of severe acute respiratory syndrome patients and inhibits growth of Balb/c 3T3 cell line. Chinese Med. J. (Engl.)118:267-274. [[PubMed]
  • 48. Cheng, V. C., I. F. Hung, B. S. Tang, C. M. Chu, M. M. Wong, K. H. Chan, A. K. Wu, D. M. Tse, K. S. Chan, B. J. Zheng, J. S. Peiris, J. J. Sung, and K. Y. Yuen. 2004. Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin. Infect. Dis.38:467-475. [[PubMed]
  • 49. Cheng, Y., R. Wong, Y. O. Soo, W. S. Wong, C. K. Lee, M. H. Ng, P. Chan, K. C. Wong, C. B. Leung, and G. Cheng. 2005. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur. J. Clin. Microbiol. Infect. Dis.24:44-46. [[PubMed]
  • 50. Cheung, C. Y., L. L. Poon, I. H. Ng, W. Luk, S. F. Sia, M. H. Wu, K. H. Chan, K. Y. Yuen, S. Gordon, Y. Guan, and J. S. Peiris. 2005. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J. Virol.79:7819-7826.
  • 51. Chinese SARS Molecular Epidemiology Consortium. 2004. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science303:1666-1669. [[PubMed]
  • 52. Chiu, S. S., K. H. Chan, K. W. Chu, S. W. Kwan, Y. Guan, L. L. Poon, and J. S. Peiris. 2005. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin. Infect. Dis.40:1721-1729. [[PubMed]
  • 53. Chu, C. M., V. C. Cheng, I. F. Hung, M. M. Wong, K. H. Chan, K. S. Chan, R. Y. Kao, L. L. Poon, C. L. Wong, Y. Guan, J. S. Peiris, and K. Y. Yuen. 2004. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax59:252-256.
  • 54. Chua, M. M., K. C. MacNamara, L. San Mateo, H. Shen, and S. R. Weiss. 2004. Effects of an epitope-specific CD8 T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants. J. Virol.78:1150-1159.
  • 55. Chua, M. M., J. J. Phillips, S. H. Seo, E. Lavi, and S. R. Weiss. 2001. Mutation of the immunodominant CD8+ epitope in the MHV-4 spike protein. Adv. Exp. Med. Biol.494:121-125. [[PubMed]
  • 56. Cinatl, J., Jr., M. Michaelis, G. Hoever, W. Preiser, and H. W. Doerr. 2005. Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res.66:81-97. [[PubMed]
  • 57. Cinatl, J., B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H. W. Doerr. 2003. Treatment of SARS with human interferons. Lancet362:293-294. [[PubMed]
  • 58. Coley, S. E., E. Lavi, S. G. Sawicki, L. Fu, B. Schelle, N. Karl, S. G. Siddell, and V. Thiel. 2005. Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo. J. Virol.79:3097-3106.
  • 59. Cook, J. K. A., and A. P. Mockett. 1995. Epidemiology of infectious bronchitis virus, p. 317-336. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
  • 60. Corapi, W. V., R. J. Darteil, J. C. Audonnet, and G. E. Chappuis. 1995. Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement. J. Virol.69:2858-2862.
  • 61. Corapi, W. V., C. W. Olsen, and F. W. Scott. 1992. Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J. Virol.66:6695-6705.
  • 62. Corse, E., and C. E. Machamer. 2003. The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction. Virology312:25-34. [[PubMed]
  • 63. Corse, E., and C. E. Machamer. 2000. Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles. J. Virol.74:4319-4326.
  • 64. Cowley, J. A., C. M. Dimmock, K. M. Spann, and P. J. Walker. 2000. Gill-associated virus of Penaeus monodon prawns: an invertebrate virus with ORF1a and ORF1b genes related to arteri- and coronaviruses. J. Gen. Virol.81:1473-1484. [[PubMed]
  • 65. Curtis, K. M., B. Yount, and R. S. Baric. 2002. Heterologous gene expression from transmissible gastroenteritis virus replicon particles. J. Virol.76:1422-1434.
  • 66. Czub, M., H. Weingartl, S. Czub, R. He, and J. Cao. 2005. Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets. Vaccine23:2273-2279. [[PubMed]
  • 67. Dalziel, R. G., P. W. Lampert, P. J. Talbot, and M. J. Buchmeier. 1986. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol.59:463-471.
  • 68. Daniel, C., R. Anderson, M. J. Buchmeier, J. O. Fleming, W. J. Spaan, H. Wege, and P. J. Talbot. 1993. Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure. J. Virol.67:1185-1194.
  • 69. Daniel, C., M. Lacroix, and P. J. Talbot. 1994. Mapping of linear antigenic sites on the S glycoprotein of a neurotropic murine coronavirus with synthetic peptides: a combination of nine prediction algorithms fails to identify relevant epitopes and peptide immunogenicity is drastically influenced by the nature of the protein carrier. Virology202:540-549. [[PubMed]
  • 70. Das Sarma, J., L. Fu, J. C. Tsai, S. R. Weiss, and E. Lavi. 2000. Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J. Virol.74:9206-9213.
  • 71. De Groot, R. J., and M. C. Horzinek. 1995. Feline infectious peritonitis, p. 293-315. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
  • 72. de Haan, C. A., M. de Wit, L. Kuo, C. Montalto-Morrison, B. L. Haagmans, S. R. Weiss, P. S. Masters, and P. J. Rottier. 2003. The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. Virology312:395-406. [[PubMed]
  • 73. de Haan, C. A., P. S. Masters, X. Shen, S. Weiss, and P. J. Rottier. 2002. The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology296:177-189. [[PubMed]
  • 74. de Haan, C. A., M. Smeets, F. Vernooij, H. Vennema, and P. J. Rottier. 1999. Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein. J. Virol.73:7441-7452.
  • 75. de Haan, C. A., K. Stadler, G. J. Godeke, B. J. Bosch, and P. J. Rottier. 2004. Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J. Virol.78:6048-6054.
  • 76. de Haan, C. A., L. van Genne, J. N. Stoop, H. Volders, and P. J. Rottier. 2003. Coronaviruses as vectors: position dependence of foreign gene expression. J. Virol.77:11312-11323.
  • 77. Ding, J. W., Q. Ning, M. F. Liu, A. Lai, J. Leibowitz, K. M. Peltekian, E. H. Cole, L. S. Fung, C. Holloway, P. A. Marsden, H. Yeger, M. J. Phillips, and G. A. Levy. 1997. Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J. Virol.71:9223-9230.
  • 78. Ding, Y., L. He, Q. Zhang, Z. Huang, X. Che, J. Hou, H. Wang, H. Shen, L. Qiu, Z. Li, J. Geng, J. Cai, H. Han, X. Li, W. Kang, D. Weng, P. Liang, and S. Jiang. 2004. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol.203:622-630. [[PubMed]
  • 79. Ding, Y., H. Wang, H. Shen, Z. Li, J. Geng, H. Han, J. Cai, X. Li, W. Kang, D. Weng, Y. Lu, D. Wu, L. He, and K. Yao. 2003. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J. Pathol.200:282-289. [[PubMed]
  • 80. Doyle, L. P., and L. M. Hutchins. 1995. Transmissible gastroenteritis in pigs. J. Am. Vet. Assoc.108:257. [[PubMed]
  • 81. Drosten, C., S. Gunther, W. Preiser, S. van der Werf, H. R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R. A. Fouchier, A. Berger, A. M. Burguiere, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J. C. Manuguerra, S. Muller, V. Rickerts, M. Sturmer, S. Vieth, H. D. Klenk, A. D. Osterhaus, H. Schmitz, and H. W. Doerr. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med.348:1967-1976. [[PubMed]
  • 82. Drosten, C., W. Preiser, S. Gunther, H. Schmitz, and H. W. Doerr. 2003. Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol. Med.9:325-327. [[PubMed]
  • 83. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol.168:3195-3204. [[PubMed]
  • 84. Dveksler, G. S., C. W. Dieffenbach, C. B. Cardellichio, K. McCuaig, M. N. Pensiero, G. S. Jiang, N. Beauchemin, and K. V. Holmes. 1993. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol.67:1-8.
  • 85. Dveksler, G. S., S. E. Gagneten, C. A. Scanga, C. B. Cardellichio, and K. V. Holmes. 1996. Expression of the recombinant anchorless N-terminal domain of mouse hepatitis virus (MHV) receptor makes hamster of human cells susceptible to MHV infection. J. Virol.70:4142-4145.
  • 86. Ebihara, T., R. Endo, X. Ma, N. Ishiguro, and H. Kikuta. 2005. Detection of human coronavirus NL63 in young children with bronchiolitis. J. Med. Virol.75:463-465. [[PubMed]
  • 87. Ebihara, T., R. Endo, X. Ma, N. Ishiguro, and H. Kikuta. 2005. Lack of association between New Haven coronavirus and Kawasaki disease. J. Infect. Dis.192:351-352. [[PubMed]
  • 88. Enjuanes, L., D. Cavanagh, K. Holmes, M. M. C. Lai, H. Laude, P. Masters, P. Rottier, S. G. Sidell, W. J. M. Spaan, F. Taguchi, and P. Talbot. 2000. Coronaviridae, p. 835-849. In M. H. V. van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carstens, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle, and R. B. Wickner (ed.), Virus taxonomy. Classification and nomemclature of viruses. Accademic Press, San Diego, Calif.
  • 89. Enjuanes, L., C. Smerdou, J. Castilla, I. M. Anton, J. M. Torres, I. Sola, J. Golvano, J. M. Sanchez, and B. Pintado. 1995. Development of protection against coronavirus induced diseases. Adv. Exp. Med. Biol.380:197-211. [[PubMed]
  • 90. Enjuanes, L., I. Sola, S. Alonso, D. Escors, and S. Zuniga. 2005. Coronavirus reverse genetics and development of vectors for gene expression. Curr. Top. Microbiol. Immunol.287:161-197. [[PubMed]
  • 91. Enjuanes, L., and B. A. M. van der Zeijst. 1995. Molecular basis of transmissible gastroenterititis virus, p. 337-376. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
  • 92. Esper, F., E. D. Shapiro, C. Weibel, D. Ferguson, M. L. Landry, and J. S. Kahn. 2005. Association between a novel human coronavirus and Kawasaki disease. J. Infect. Dis.191:499-502. [[PubMed]
  • 93. Esper, F., C. Weibel, D. Ferguson, M. L. Landry, and J. S. Kahn. 2005. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J. Infect. Dis.191:492-498. [[PubMed]
  • 94. Faber, M., E. W. Lamirande, A. Roberts, A. B. Rice, H. Koprowski, B. Dietzschold, and M. J. Schnell. 2005. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies. J. Gen. Virol.86:1435-1440.
  • 95. Farcas, G. A., S. M. Poutanen, T. Mazzulli, B. M. Willey, J. Butany, S. L. Asa, P. Faure, P. Akhavan, D. E. Low, and K. C. Kain. 2005. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J. Infect. Dis.191:193-197. [[PubMed]
  • 96. Fielding, B. C., Y. J. Tan, S. Shuo, T. H. Tan, E. E. Ooi, S. G. Lim, W. Hong, and P. Y. Goh. 2004. Characterization of a unique group-specific protein (U122) of the severe acute respiratory syndrome coronavirus. J. Virol.78:7311-7318.
  • 97. Fischer, F., D. Peng, S. T. Hingley, S. R. Weiss, and P. S. Masters. 1997. The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication. J. Virol.71:996-1003.
  • 98. Fischer, F., C. F. Stegen, C. A. Koetzner, and P. S. Masters. 1997. Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription. J. Virol.71:5148-5160.
  • 99. Fisman, DN. 2000. Hemophagocytic syndromes and infection. Emerg. Infect. Dis.6:601-608. [Google Scholar]
  • 100. Fleck, F. 2003. WHO says SARS outbreak is over, but fight should go on. Br. Med. J.327:70.
  • 101. Fouchier, R. A., N. G. Hartwig, T. M. Bestebroer, B. Niemeyer, J. C. de Jong, J. H. Simon, and A. D. Osterhaus. 2004. A previously undescribed coronavirus associated with respiratory disease in humans. Proc. Natl. Acad. Sci. USA101:6212-6216.
  • 102. Fouchier, R. A., T. Kuiken, M. Schutten, G. Van Amerongen, G. J. Van Doornum, B. G. Van Den Hoogen, M. Peiris, W. Lim, K. Stohr, and A. D. Osterhaus. 2003. Aetiology: Koch's postulates fulfilled for SARS virus. Nature423:240. [[PubMed]
  • 103. Gallagher, T. M., and M. J. Buchmeier. 2001. Coronavirus spike proteins in viral entry and pathogenesis. Virology279:371-374. [[PubMed]
  • 104. Gallagher, T. M., M. J. Buchmeier, and S. Perlman. 1992. Cell receptor-independent infection by a neurotropic murine coronavirus. Virology191:517-522. [[PubMed]
  • 105. Gallagher, T. M., C. Escarmis, and M. J. Buchmeier. 1991. Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J. Virol.65:1916-1928.
  • 106. Gallagher, T. M., S. E. Parker, and M. J. Buchmeier. 1990. Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. J. Virol.64:731-741.
  • 107. Gao, W., A. Tamin, A. Soloff, L. D'Aiuto, E. Nwanegbo, P. D. Robbins, W. J. Bellini, S. Barratt-Boyes, and A. Gambotto. 2003. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet362:1895-1896. [[PubMed]
  • 108. Gilmore, W., J. O. Fleming, S. A. Stohlman, and L. P. Weiner. 1987. Characterization of the structural proteins of the murine coronavirus strain A59 using monoclonal antibodies. Proc. Soc. Exp. Biol. Med.185:177-186. [[PubMed]
  • 109. Glass, W. G., B. P. Chen, M. T. Liu, and T. E. Lane. 2002. Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease. Viral Immunol.15:261-272. [[PubMed]
  • 110. Glass, W. G., K. Subbarao, B. Murphy, and P. M. Murphy. 2004. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J. Immunol.173:4030-4039. [[PubMed]
  • 111. Godfraind, C., S. G. Langreth, C. B. Cardellichio, R. Knobler, J. P. Coutelier, M. Dubois-Dalcq, and K. V. Holmes. 1995. Tissue and cellular distribution of an adhesion molecule in the carcinoembryonic antigen family that serves as a receptor for mouse hepatitis virus. Lab. Invest.73:615-627. [[PubMed]
  • 112. Goebel, S. J., B. Hsue, T. F. Dombrowski, and P. S. Masters. 2004. Characterization of the RNA components of a putative molecular switch in the 3′ untranslated region of the murine coronavirus genome. J. Virol.78:669-682.
  • 113. Goebel, S. J., J. Taylor, and P. S. Masters. 2004. The 3′ cis-acting genomic replication element of the severe acute respiratory syndrome coronavirus can function in the murine coronavirus genome. J. Virol.78:7846-7851.
  • 114. Gombold, J. L., S. T. Hingley, and S. R. Weiss. 1993. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol.67:4504-4512.
  • 115. Gonzalez, J. M., P. Gomez-Puertas, D. Cavanagh, A. E. Gorbalenya, and L. Enjuanes. 2003. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch. Virol.148:2207-2235. [[PubMed]
  • 116. Gorbalenya, AE. 2001. Big nidovirus genome. When count and order of domains matter. Adv. Exp. Med. Biol.494:1-17. [[PubMed][Google Scholar]
  • 117. Gorbalenya, A. E., E. J. Snijder, and W. J. Spaan. 2004. Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J. Virol.78:7863-7866.
  • 118. Greenough, T. C., G. J. Babcock, A. Roberts, H. J. Hernandez, W. D. Thomas, Jr., J. A. Coccia, R. F. Graziano, M. Srinivasan, I. Lowy, R. W. Finberg, K. Subbarao, L. Vogel, M. Somasundaran, K. Luzuriaga, J. L. Sullivan, and D. M. Ambrosino. 2005. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J. Infect. Dis.191:507-514. [[PubMed]
  • 119. Greenough, T. C., A. Carville, J. Coderre, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, and K. Mansfield. 2005. Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus. Am. J. Pathol.167:455-463.
  • 120. Groneberg, D. A., S. M. Poutanen, D. E. Low, H. Lode, T. Welte, and P. Zabel. 2005. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect. Dis.5:147-155. [[PubMed]
  • 121. Grosse, B., and S. G. Siddell. 1994. Single amino acid changes in the S2 subunit of the MHV surface glycoprotien confer resistance to neutralization by S1 subunit-specific monoclonal antibody. Virology202:814-824. [[PubMed]
  • 122. Guan, Y., B. J. Zheng, Y. Q. He, X. L. Liu, Z. X. Zhuang, C. L. Cheung, S. W. Luo, P. H. Li, L. J. Zhang, Y. J. Guan, K. M. Butt, K. L. Wong, K. W. Chan, W. Lim, K. F. Shortridge, K. Y. Yuen, J. S. Peiris, and L. L. Poon. 2003. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science302:276-278. [[PubMed]
  • 123. Haagmans, B. L., T. Kuiken, B. E. Martina, R. A. Fouchier, G. F. Rimmelzwaan, G. van Amerongen, D. van Riel, T. de Jong, S. Itamura, K. H. Chan, M. Tashiro, and A. D. Osterhaus. 2004. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med.10:290-293. [[PubMed]
  • 124. Haijema, B. J., H. Volders, and P. J. Rottier. 2004. Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J. Virol.78:3863-3871.
  • 125. Haijema, B. J., H. Volders, and P. J. Rottier. 2003. Switching species tropism: an effective way to manipulate the feline coronavirus genome. J. Virol.77:4528-4538.
  • 126. Hamming, I., W. Timens, M. L. Bulthuis, A. T. Lely, G. J. Navis, and H. van Goor. 2004. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol.203:631-637. [[PubMed]
  • 127. Haring, J. S., L. L. Pewe, and S. Perlman. 2001. High-magnitude, virus-specific CD4 T-cell response in the central nervous system of coronavirus-infected mice. J. Virol.75:3043-3307.
  • 128. He, R., F. Dobie, M. Ballantine, A. Leeson, Y. Li, N. Bastien, T. Cutts, A. Andonov, J. Cao, T. F. Booth, F. A. Plummer, S. Tyler, L. Baker, and X. Li. 2004. Analysis of multimerization of the SARS coronavirus nucleocapsid protein. Biochem. Biophys. Res. Commun.316:476-483. [[PubMed]
  • 129. Held, K. S., B. P. Chen, W. A. Kuziel, B. J. Rollins, and T. E. Lane. 2004. Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. Virology329:251-260. [[PubMed]
  • 130. Hellebo, A., U. Vilas, K. Falk, and R. Vlasak. 2004. Infectious salmon anemia virus specifically binds to and hydrolyzes 4-O-acetylated sialic acids. J. Virol.78:3055-3062.
  • 131. Hemmila, E., C. Turbide, M. Olson, S. Jothy, K. V. Holmes, and N. Beauchemin. 2004. Ceacam1a mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. J. Virol.78:10156-10165.
  • 132. Hingley, S. T., I. Leparc-Goffart, S. H. Seo, J. C. Tsai, and S. R. Weiss. 2002. The virulence of mouse hepatitis virus strain A59 is not dependent on efficient spike protein cleavage and cell-to-cell fusion. J. Neurovirol.8:400-410. [[PubMed]
  • 133. Hingley, S. T., I. Leparc-Goffart, and S. R. Weiss. 1998. The spike protein of murine coronavirus mouse hepatitis virus strain A59 is not cleaved in primary glial cells and primary hepatocytes. J. Virol.72:1606-1609.
  • 134. Hodgson, T., R. Casais, B. Dove, P. Britton, and D. Cavanagh. 2004. Recombinant infectious bronchitis coronavirus Beaudette with the spike protein gene of the pathogenic M41 strain remains attenuated but induces protective immunity. J. Virol.78:13804-13811.
  • 135. Hofmann, H., and SPohlmann. 2004. Cellular entry of the SARS coronavirus. Trends Microbiol.12:466-472. [[PubMed][Google Scholar]
  • 136. Hofmann, H., K. Pyrc, L. van der Hoek, M. Geier, B. Berkhout, and S. Pohlmann. 2005. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl. Acad. Sci. USA102:7988-7993.
  • 137. Hogan, R. J., G. Gao, T. Rowe, P. Bell, D. Flieder, J. Paragas, G. P. Kobinger, N. A. Wivel, R. G. Crystal, J. Boyer, H. Feldmann, T. G. Voss, and J. M. Wilson. 2004. Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1. J. Virol.78:11416-11421.
  • 138. Hohdatsu, T., M. Yamada, R. Tominaga, K. Makino, K. Kida, and H. Koyama. 1998. Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus. J. Vet. Med. Sci.60:49-55. [[PubMed]
  • 139. Holmes, KV. 1996. Coronaviridae: the viruses and their replication, p. 1075-1103. In D. M. Knipe, P. M. Howley, and B. N. Fields (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.[Google Scholar]
  • 140. Holmes, KV. 2003. SARS coronavirus: a new challenge for prevention and therapy. J. Clin. Investig.111:1605-1609. [Google Scholar]
  • 141. Holmes, K. V., and S. R. Compton. 1995. Coronavirus receptors, p. 5571. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
  • 142. Holmes, K. V., and L. Enjuanes. 2003. Virology. The SARS coronavirus: a postgenomic era. Science300:1377-1378. [[PubMed]
  • 143. Ito, N., E. C. Mossel, K. Narayanan, V. L. Popov, C. Huang, T. Inoue, C. J. Peters, and S. Makino. 2005. Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J. Virol.79:3182-3186.
  • 144. Ivanov, K. A., T. Hertzig, M. Rozanov, S. Bayer, V. Thiel, A. E. Gorbalenya, and J. Ziebuhr. 2004. Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proc. Natl. Acad. Sci. USA101:12694-12699.
  • 145. Jeffers, S. A., S. M. Tusell, L. Gillim-Ross, E. M. Hemmila, J. E. Achenbach, G. J. Babcock, W. D. Thomas, Jr., L. B. Thackray, M. D. Young, R. J. Mason, D. M. Ambrosino, D. E. Wentworth, J. C. Demartini, and K. V. Holmes. 2004. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA101:15748-15753.
  • 146. Jendrach, M., V. Thiel, and S. Siddell. 1999. Characterization of an internal ribosome entry site within mRNA 5 of murine hepatitis virus. Arch. Virol.144:921-933. [[PubMed]
  • 147. Jonassen, C. M., T. Kofstad, I. L. Larsen, A. Lovland, K. Handeland, A. Follestad, and A. Lillehaug. 2005. Molecular identification and characterization of novel coronaviruses infecting graylag geese (Anser anser), feral pigeons (Columbia livia) and mallards (Anas platyrhynchos). J. Gen. Virol.86:1597-1607. [[PubMed]
  • 148. Kapadia, S. U., J. K. Rose, E. Lamirande, L. Vogel, K. Subbarao, and A. Roberts. 2005. Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. Virology340:174-182. [[PubMed]
  • 149. Kazi, L., A. Lissenburg, R. Watson, R. J. deGroot, and S. Weiss. Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence. J. Virol., in press.
  • 150. Keck, J. G., L. H. Soe, S. Makino, S. A. Stohlman, and M. M. Lai. 1988. RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J. Virol.62:1989-1998.
  • 151. Kienzle, T. E., S. Abraham, B. G. Hogue, and D. A. Brian. 1990. Structure and orientation of expressed bovine coronavirus hemagglutinin-esterase protein. J. Virol.64:1834-1838.
  • 152. Kim, T. S., and S. Perlman. 2003. Protection against CTL escape and clinical disease in a murine model of virus persistence. J. Immunol.171:2006-2013. [[PubMed]
  • 153. Kim, T. W., J. H. Lee, C. F. Hung, S. Peng, R. Roden, M. C. Wang, R. Viscidi, Y. C. Tsai, L. He, P. J. Chen, D. A. Boyd, and T. C. Wu. 2004. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J. Virol.78:4638-4645.
  • 154. Klumperman, J., J. K. Locker, A. Meijer, M. C. Horzinek, H. J. Geuze, and P. J. Rottier. 1994. Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J. Virol.68:6523-6534.
  • 155. Koetzner, C. A., M. M. Parker, C. S. Ricard, L. S. Sturman, and P. S. Masters. 1992. Repair and mutagenesis of the genome of a deletion mutant of the coronavirus mouse hepatitis virus by targeted RNA recombination. J. Virol.66:1841-1848.
  • 156. Kooi, C., M. Cervin, and R. Anderson. 1991. Differentiation of acid-pH-dependent and -nondependent entry pathways for mouse hepatitis virus. Virology180:108-119. [[PubMed]
  • 157. Koren, G., S. King, S. Knowles, and E. Phillips. 2003. Ribavirin in the treatment of SARS: a new trick for an old drug? Can. Med. Assoc. J.168:1289-1292.
  • 158. Kozak, M. 1984. Compilation and anlaysis of sequences upstream from the translational start site in eukaryotic mRNA. Nucleic Acids Res.12:857-872.
  • 159. Krempl, C., B. Schultze, and G. Herrler. 1995. Analysis of cellular receptors for human coronavirus OC43. Adv. Exp. Med. Biol.380:371-374. [[PubMed]
  • 160. Krijnse-Locker, J., M. Ericsson, P. J. Rottier, and G. Griffiths. 1994. Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J. Cell Biol.124:55-70.
  • 161. Krueger, D. K., S. M. Kelly, D. N. Lewicki, R. Ruffolo, and T. M. Gallagher. 2001. Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion. J. Virol.75:2792-2802.
  • 162. Ksiazek, T. G., D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Comer, W. Lim, P. E. Rollin, S. F. Dowell, A. E. Ling, C. D. Humphrey, W. J. Shieh, J. Guarner, C. D. Paddock, P. Rota, B. Fields, J. DeRisi, J. Y. Yang, N. Cox, J. M. Hughes, J. W. LeDuc, W. J. Bellini, and L. J. Anderson. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med.348:1953-1966. [[PubMed]
  • 163. Kubo, H., Y. K. Yamada, and F. Taguchi. 1994. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol.68:5403-5410.
  • 164. Kuiken, T., R. A. Fouchier, M. Schutten, G. F. Rimmelzwaan, G. van Amerongen, D. van Riel, J. D. Laman, T. de Jong, G. van Doornum, W. Lim, A. E. Ling, P. K. Chan, J. S. Tam, M. C. Zambon, R. Gopal, C. Drosten, S. van der Werf, N. Escriou, J. C. Manuguerra, K. Stohr, J. S. Peiris, and A. D. Osterhaus. 2003. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet362:263-270. [[PubMed]
  • 165. Künkel, F., and GHerrler. 1993. Structural and functional analysis of the surface protein of human coronavirus OC43. Virology195:195-202. [[PubMed][Google Scholar]
  • 166. Kuo, L., G. J. Godeke, M. J. Raamsman, P. S. Masters, and P. J. Rottier. 2000. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J. Virol.74:1393-1406.
  • 167. Kuo, L., and P. S. Masters. 2002. Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J. Virol.76:4987-4999.
  • 168. Kuo, L., and P. S. Masters. 2003. The small envelope protein E is not essential for murine coronavirus replication. J. Virol.77:4597-4608.
  • 169. Lai, K. N., J. C. Leung, C. N. Metz, F. M. Lai, R. Bucala, and H. Y. Lan. 2003. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J. Pathol.199:496-508. [[PubMed]
  • 170. Lai, M. M., R. S. Baric, P. R. Brayton, and S. A. Stohlman. 1984. Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc. Natl. Acad. Sci. USA81:3626-3630.
  • 171. La Monica, N., K. Yokomori, and M. M. Lai. 1992. Coronavirus mRNA synthesis: identification of novel transcription initiation signals which are differentially regulated by different leader sequences. Virology188:402-407. [[PubMed]
  • 172. LaMonica, N., L. R. Banner, V. L. Morris, and M. M. C. Lai. 1991. Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM. Virology182:883-888. [[PubMed]
  • 173. Lane, T. E., V. C. Asensio, N. Yu, A. D. Paoletti, I. L. Campbell, and M. J. Buchmeier. 1998. Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J. Immunol.160:970-978. [[PubMed]
  • 174. Lapps, W., B. G. Hogue, and D. A. Brian. 1987. Sequence analysis of the bovine coronavirus nucleocapsid and matrix protein genes. Virology157:47-57. [[PubMed]
  • 175. Laude, H., J. Gelfi, L. Lavenant, and B. Charley. 1992. Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J. Virol.66:743-749.
  • 176. Law, H. K., C. Y. Cheung, H. Y. Ng, S. F. Sia, Y. O. Chan, W. Luk, J. M. Nicholls, J. S. Peiris, and Y. L. Lau. 2005. Chemokine upregulation in SARS coronavirus infected human monocyte derived dendritic cells. Blood106:2366-2374.
  • 177. Law, P. T., C. H. Wong, T. C. Au, C. P. Chuck, S. K. Kong, P. K. Chan, K. F. To, A. W. Lo, J. Y. Chan, Y. K. Suen, H. Y. Chan, K. P. Fung, M. M. Waye, J. J. Sung, Y. M. Lo, and S. K. Tsui. 2005. The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells. J. Gen. Virol.86:1921-1930. [[PubMed]
  • 178. Lee, H. J., C. K. Shieh, A. E. Gorbalenya, E. V. Koonin, N. La Monica, J. Tuler, A. Bagdzhadzhyan, and M. M. Lai. 1991. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology180:567-582. [[PubMed]
  • 179. Lee, N., D. Hui, A. Wu, P. Chan, P. Cameron, G. M. Joynt, A. Ahuja, M. Y. Yung, C. B. Leung, K. F. To, S. F. Lui, C. C. Szeto, S. Chung, and J. J. Sung. 2003. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med.348:1986-1994. [[PubMed]
  • 180. Leparc-Goffart, I., S. T. Hingley, M. M. Chua, X. Jiang, E. Lavi, and S. R. Weiss. 1997. Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein. Virology239:1-10. [[PubMed]
  • 181. Leparc-Goffart, I., S. T. Hingley, M. M. Chua, J. Phillips, E. Lavi, and S. R. Weiss. 1998. Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J. Virol.72:9628-9636.
  • 182. Leung, W. K., K. F. To, P. K. Chan, H. L. Chan, A. K. Wu, N. Lee, K. Y. Yuen, and J. J. Sung. 2003. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology125:1011-1017. [[PubMed]
  • 183. Li, B. J., Q. Tang, D. Cheng, C. Qin, F. Y. Xie, Q. Wei, J. Xu, Y. Liu, B. J. Zheng, M. C. Woodle, N. Zhong, and P. Y. Lu. 2005. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque. Nat. Med.11:944-951. [[PubMed]
  • 184. Li, L., J. Wo, J. Shao, H. Zhu, N. Wu, M. Li, H. Yao, M. Hu, and R. H. Dennin. 2003. SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. J. Clin. Virol.28:239-244. [[PubMed]
  • 185. Li, T., Z. Qiu, L. Zhang, Y. Han, W. He, Z. Liu, X. Ma, H. Fan, W. Lu, J. Xie, H. Wang, G. Deng, and A. Wang. 2004. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J. Infect. Dis.189:648-651. [[PubMed]
  • 186. Li, T., Y. Zhang, L. Fu, C. Yu, X. Li, Y. Li, X. Zhang, Z. Rong, Y. Wang, H. Ning, R. Liang, W. Chen, L. A. Babiuk, and Z. Chang. 2005. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication. Gene Ther.12:751-761. [[PubMed]
  • 187. Li, W., M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, T. C. Greenough, H. Choe, and M. Farzan. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature426:450-454. [[PubMed]
  • 188. Li, W., C. Zhang, J. Sui, J. H. Kuhn, M. J. Moore, S. Luo, S. K. Wong, I. C. Huang, K. Xu, N. Vasilieva, A. Murakami, Y. He, W. A. Marasco, Y. Guan, H. Choe, and M. Farzan. 2005. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J.24:1634-1643.
  • 189. Lin, M. T., D. R. Hinton, N. W. Marten, C. C. Bergmann, and S. A. Stohlman. 1999. Antibody prevents virus reactivation within the central nervous system. J. Immunol.162:7358-7368. [[PubMed]
  • 190. Lissenburg, A., M. Vrolijk, A. van Vliet, M. Langereis, J. de Groot-Mijnes, P. Rottier, and R. J. de Groot. Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro. Submitted for publication.
  • 191. Liu, M. T., B. P. Chen, P. Oertel, M. J. Buchmeier, D. Armstrong, T. A. Hamilton, and T. E. Lane. 2000. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J. Immunol.165:2327-2330. [[PubMed]
  • 192. Liu, M. T., and T. E. Lane. 2001. Chemokine expression and viral infection of the central nervous system: regulation of host defense and neuropathology. Immunol. Res.24:111-119. [[PubMed]
  • 193. Liu, S., G. Xiao, Y. Chen, Y. He, J. Niu, C. R. Escalante, H. Xiong, J. Farmar, A. K. Debnath, P. Tien, and S. Jiang. 2004. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet363:938-947. [[PubMed]
  • 194. Liu, Y. C., V. Huang, T. C. Chao, C. D. Hsiao, A. Lin, M. F. Chang, and L. P. Chow. 2005. Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease. Biochem. Biophys. Res. Commun.333:194-199. [[PubMed]
  • 195. Liu, Z., C. Huang, K. Fan, P. Wei, H. Chen, S. Liu, J. Pei, L. Shi, B. Li, K. Yang, Y. Liu, and L. Lai. 2005. Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase. J. Chem. Inf Model.45:10-17. [[PubMed]
  • 196. Lomniczi, BJ. 1977. Biological properties of avian coronavirus RNA. Gen. Virol.36:531-533. [[PubMed][Google Scholar]
  • 197. Luo, Z., A. M. Matthews, and S. R. Weiss. 1999. Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion. J. Virol.73:8152-8159.
  • 198. Luo, Z., and S. R. Weiss. 1998. Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein. Virology244:483-494. [[PubMed]
  • 199. Luytjes, W., P. J. Bredenbeek, A. F. Noten, M. C. Horzinek, and W. J. Spaan. 1988. Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology166:415-422. [[PubMed]
  • 200. MacNamara, K. C., M. M. Chua, P. T. Nelson, H. Shen, and S. R. Weiss. 2005. Increased epitope-specific CD8 T cells prevent murine coronavirus spread to the spinal cord and subsequent demyelination. J. Virol.79:3370-3381.
  • 201. MacNamara, K. C., M. M. Chua, J. J. Phillips, and S. R. Weiss. 2005. Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8 T-cell epitope to murine coronavirus neurovirulence. J. Virol.79:9108-9118.
  • 202. Maeda, J., J. F. Repass, A. Maeda, and S. Makino. 2001. Membrane topology of coronavirus E protein. Virology281:163-169. [[PubMed]
  • 203. Magiorkinis, G., E. Magiorkinis, D. Paraskevis, A. M. Vandamme, M. Van Ranst, V. Moulton, and A. Hatzakis. 2004. Phylogenetic analysis of the full-length SARS-CoV sequences: evidence for phylogenetic discordance in three genomic regions. J. Med. Virol.74:369-372. [[PubMed]
  • 204. Makino, S., J. G. Keck, S. A. Stohlman, and M. M. Lai. 1986. High-frequency RNA recombination of murine coronaviruses. J. Virol.57:729-737.
  • 205. Marra, M. A., S. J. Jones, C. R. Astell, R. A. Holt, A. Brooks-Wilson, Y. S. Butterfield, J. Khattra, J. K. Asano, S. A. Barber, S. Y. Chan, A. Cloutier, S. M. Coughlin, D. Freeman, N. Girn, O. L. Griffith, S. R. Leach, M. Mayo, H. McDonald, S. B. Montgomery, P. K. Pandoh, A. S. Petrescu, A. G. Robertson, J. E. Schein, A. Siddiqui, D. E. Smailus, J. M. Stott, G. S. Yang, F. Plummer, A. Andonov, H. Artsob, N. Bastien, K. Bernard, T. F. Booth, D. Bowness, M. Czub, M. Drebot, L. Fernando, R. Flick, M. Garbutt, M. Gray, A. Grolla, S. Jones, H. Feldmann, A. Meyers, A. Kabani, Y. Li, S. Normand, U. Stroher, G. A. Tipples, S. Tyler, R. Vogrig, D. Ward, B. Watson, R. C. Brunham, M. Krajden, M. Petric, D. M. Skowronski, C. Upton, and R. L. Roper. 2003. The genome sequence of the SARS-associated coronavirus. Science300:1399-1404. [[PubMed]
  • 206. Marten, N. W., S. A. Stohlman, and C. C. Bergmann. 2001. MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol.14:1-18. [[PubMed]
  • 207. Martina, B. E., B. L. Haagmans, T. Kuiken, R. A. Fouchier, G. F. Rimmelzwaan, G. Van Amerongen, J. S. Peiris, W. Lim, and A. D. Osterhaus. 2003. SARS virus infection of cats and ferrets. Nature425:915. [[PubMed]
  • 208. Masters, PS. 1999. Reverse genetics of the largest RNA viruses. Adv. Virus Res.53:245-264. [[PubMed][Google Scholar]
  • 209. Masters, P. S., and P. J. Rottier. 2005. Coronavirus reverse genetics by targeted RNA recombination. Curr. Top. Microbiol. Immunol.287:133-159. [[PubMed]
  • 210. Matrosovich, M. N., T. Y. Matrosovich, T. Gray, N. A. Roberts, and H. D. Klenk. 2004. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA101:4620-4624.
  • 211. Matsuyama, S., and FTaguchi. 2002. Communication between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAM1b receptor. Virology295:160-171. [[PubMed][Google Scholar]
  • 212. Matsuyama, S., and FTaguchi. 2002. Receptor-induced conformational changes of murine coronavirus spike protein. J. Virol.76:11819-11826. [Google Scholar]
  • 213. Matsuyama, S., M. Ujike, S. Morikawa, M. Tashiro, and F. Taguchi. 2005. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc. Natl. Acad. Sci. USA102:12543-12547.
  • 214. Matthews, A. E., S. R. Weiss, and Y. Paterson. 2002. Murine hepatitis virus—a model for virus-induced CNS demyelination. J. Neurovirol.8:76-85. [[PubMed]
  • 215. Matthews, A. E., S. R. Weiss, M. J. Shlomchik, L. G. Hannum, J. L. Gombold, and Y. Paterson. 2001. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. J. Immunol.167:5254-5263. [[PubMed]
  • 216. McAuliffe, J., L. Vogel, A. Roberts, G. Fahle, S. Fischer, W. J. Shieh, E. Butler, S. Zaki, M. St Claire, B. Murphy, and K. Subbarao. 2004. Replication of SARS coronavirus administered into the respiratory tract of African green, rhesus and cynomolgus monkeys. Virology330:8-15. [[PubMed]
  • 217. McGoldrick, A., J. P. Lowings, and D. J. Paton. 1999. Characterisation of a recent virulent transmissible gastroenteritis virus from Britain with a deleted ORF 3a. Arch. Virol.144:763-770. [[PubMed]
  • 218. McIntosh, K. 1974. Coronaviruses: a comparative review. Curr. Top. Microbiol. Immunol.63:85-129. [PubMed]
  • 219. Mizzen, L., A. Hilton, S. Cheley, and R. Anderson. 1985. Attenuation of murine coronavirus infection by ammonium chloride. Virology142:378-388. [[PubMed]
  • 220. Moes, E., L. Vijgen, E. Keyaerts, K. Zlateva, S. Li, P. Maes, K. Pyrc, B. Berkhout, L. van der Hoek, and M. Van Ranst. 2005. A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect. Dis.5:6.
  • 221. Nash, T. C., and M. J. Buchmeier. 1997. Entry of mouse hepatitis virus into cells by endosomal and nonendosomal pathways. Virology233:1-8. [[PubMed]
  • 222. Navas, S., S. H. Seo, M. M. Chua, J. D. Sarma, E. Lavi, S. T. Hingley, and S. R. Weiss. 2001. Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. J. Virol.75:2452-2457.
  • 223. Navas, S., and S. R. Weiss. 2003. Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropism. J. Virol.77:4972-4978.
  • 224. Navas-Martin, S., S. T. Hingley, and S. R. Weiss. 2005. Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein. J. Virol.79:7629-7640.
  • 225. Navas-Martin, S. R., and S. Weiss. 2004. Coronavirus replication and pathogenesis: implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. J. Neurovirol.10:75-85. [[PubMed]
  • 226. Nedellec, P., G. S. Dveksler, E. Daniels, C. Turbide, B. Chow, A. A. Basile, K. V. Holmes, and N. Beauchemin. 1994. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J. Virol.68:4525-4537.
  • 227. Nelson, C. A., A. Pekosz, C. A. Lee, M. S. Diamond, and D. H. Fremont. 2005. Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein. Structure (Cambridge)13:75-85. [[PubMed]
  • 228. Nicholls, J. M., L. L. Poon, K. C. Lee, W. F. Ng, S. T. Lai, C. Y. Leung, C. M. Chu, P. K. Hui, K. L. Mak, W. Lim, K. W. Yan, K. H. Chan, N. C. Tsang, Y. Guan, K. Y. Yuen, and J. S. Peiris. 2003. Lung pathology of fatal severe acute respiratory syndrome. Lancet361:1773-1778. [[PubMed]
  • 229. Nie, Q. H., X. D. Luo, J. Z. Zhang, and Q. Su. 2003. Current status of severe acute respiratory syndrome in China. World J. Gastroenterol.9:1635-1645.
  • 230. Ning, Q., M. Liu, P. Kongkham, M. M. Lai, P. A. Marsden, J. Tseng, B. Pereira, M. Belyavskyi, J. Leibowitz, M. J. Phillips, and G. Levy. 1999. The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene. J. Biol. Chem.274:9930-9936. [[PubMed]
  • 231. Ontiveros, E., T. S. Kim, T. M. Gallagher, and S. Perlman. 2003. Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus strain JHM, is associated with a glycine at residue 310 of the spike glycoprotein. J. Virol.77:10260-10269.
  • 232. Ontiveros, E., L. Kuo, P. S. Masters, and S. Perlman. 2001. Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. Virology289:230-238. [[PubMed]
  • 233. Ortego, J., D. Escors, H. Laude, and L. Enjuanes. 2002. Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome. J. Virol.76:11518-11529.
  • 234. Ortego, J., I. Sola, F. Almazan, J. E. Ceriani, C. Riquelme, M. Balasch, J. Plana, and L. Enjuanes. 2003. Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence. Virology308:13-22. [[PubMed]
  • 235. Parisien, J. P., J. F. Lau, J. J. Rodriguez, B. M. Sullivan, A. Moscona, G. D. Parks, R. A. Lamb, and C. M. Horvath. 2001. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology283:230-239. [[PubMed]
  • 236. Parker, S. E., T. M. Gallagher, and M. J. Buchmeier. 1989. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology173:664-673. [[PubMed]
  • 237. Parra, B., D. R. Hinton, N. W. Marten, C. C. Bergmann, M. T. Lin, C. S. Yang, and S. A. Stohlman. 1999. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol.162:1641-1647. [[PubMed]
  • 238. Parry, J. 2003. WHO investigates China's fall in SARS cases. Br. Med. J.326:1285.
  • 239. Pearce, B. D., M. V. Hobbs, T. S. McGraw, and M. J. Buchmeier. 1994. Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol.68:5483-5495.
  • 240. Peiris, J. S., C. M. Chu, V. C. Cheng, K. S. Chan, I. F. Hung, L. L. Poon, K. I. Law, B. S. Tang, T. Y. Hon, C. S. Chan, K. H. Chan, J. S. Ng, B. J. Zheng, W. L. Ng, R. W. Lai, Y. Guan, and K. Y. Yuen. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet361:1767-1772. [[PubMed]
  • 241. Peiris, J. S., Y. Guan, and K. Y. Yuen. 2004. Severe acute respiratory syndrome. Nat. Med.10:S88-97. [[PubMed]
  • 242. Perlman, S. 1998. Pathogenesis of coronavirus-induced infections. Review of pathological and immunological aspects. Adv. Exp. Med. Biol.440:503-513. [[PubMed]
  • 243. Pewe, L., G. F. Wu, E. M. Barnett, R. F. Castro, and S. Perlman. 1996. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity5:253-262. [[PubMed]
  • 244. Pfleiderer, M., E. Routledge, G. Herrler, and S. G. Siddell. 1991. High level transient expression of the murine coronavirus haemagglutinin-esterase. J. Gen. Virol.72:1309-1315. [[PubMed]
  • 245. Phillips, J. J., M. Chua, S. H. Seo, and S. R. Weiss. 2001. Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence. J. Neurovirol.7:421-431. [[PubMed]
  • 246. Phillips, J. J., M. M. Chua, E. Lavi, and S. R. Weiss. 1999. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J. Virol.73:7752-7760.
  • 247. Phillips, J. J., M. M. Chua, G. F. Rall, and S. R. Weiss. 2002. Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system. Virology301:109-120. [[PubMed]
  • 248. Phillips, J. J., and S. R. Weiss. 2001. MHV neuropathogenesis: the study of chimeric S genes and mutations in the hypervariable region. Adv. Exp. Med. Biol.494:115-119. [[PubMed]
  • 249. Poon, L. L., D. K. Chu, K. H. Chan, O. K. Wong, T. M. Ellis, Y. H. Leung, S. K. Lau, P. C. Woo, K. Y. Suen, K. Y. Yuen, Y. Guan, and J. S. Peiris. 2005. Identification of a novel coronavirus in bats. J. Virol.79:2001-2009.
  • 250. Poon, L. L., Y. Guan, J. M. Nicholls, K. Y. Yuen, and J. S. Peiris. 2004. The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect. Dis.4:663-671. [[PubMed]
  • 251. Poon, L. L., C. S. Leung, K. H. Chan, K. Y. Yuen, Y. Guan, and J. S. Peiris. 2005. Recurrent mutations associated with isolation and passage of SARS coronavirus in cells from non-human primates. J. Med. Virol.76:435-440. [[PubMed]
  • 252. Poon, L. L., O. K. Wong, K. H. Chan, W. Luk, K. Y. Yuen, J. S. Peiris, and Y. Guan. 2003. Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin. Chem.49:953-955. [[PubMed]
  • 253. Popova, R., and XZhang. 2002. The spike but not the hemagglutinin/esterase protein of bovine coronavirus is necessary and sufficient for viral infection. Virology294:222-236. [[PubMed][Google Scholar]
  • 254. Prentice, E., J. McAuliffe, X. Lu, K. Subbarao, and M. R. Denison. 2004. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. J. Virol.78:9977-9986.
  • 255. Qin, C., J. Wang, Q. Wei, M. She, W. A. Marasco, H. Jiang, X. Tu, H. Zhu, L. Ren, H. Gao, L. Guo, L. Huang, R. Yang, Z. Cong, Y. Wang, Y. Liu, Y. Sun, S. Duan, J. Qu, L. Chen, W. Tong, L. Ruan, P. Liu, H. Zhang, J. Zhang, D. Liu, Q. Liu, T. Hong, and W. He. 2005. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J. Pathol.206:251-259. [[PubMed]
  • 256. Qu, X. X., P. Hao, X. J. Song, S. M. Jiang, Y. X. Liu, P. G. Wang, X. Rao, H. D. Song, S. Y. Wang, Y. Zuo, A. H. Zheng, M. Luo, H. L. Wang, F. Deng, H. Z. Wang, Z. H. Hu, M. X. Ding, G. P. Zhao, and H. Deng. 2005. Identification of two critical amino acid residues of the SARS coronavirus spike protein for its variation in zoonotic tropism transition via a double-substitution strategy. J. Biol. Chem.280:29588-29595. [[PubMed]
  • 257. Ramakrishna, C., C. C. Bergmann, K. V. Holmes, and S. A. Stohlman. 2004. Expression of the mouse hepatitis virus receptor by central nervous system microglia. J. Virol.78:7828-7832.
  • 258. Reghunathan, R., M. Jayapal, L. Y. Hsu, H. H. Chng, D. Tai, B. P. Leung, and A. J. Melendez. 2005. Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunol.6:2.
  • 259. Regl, G., A. Kaser, M. Iwersen, H. Schmid, G. Kohla, B. Strobl, U. Vilas, R. Schauer, and R. Vlasak. 1999. The hemagglutinin-esterase of mouse hepatitis virus strain S is a sialate-4-O-acetylesterase. J. Virol.73:4721-4727.
  • 260. Rempel, J. D., S. J. Murray, J. Meisner, and M. J. Buchmeier. 2004. Mouse hepatitis virus neurovirulence: evidence of a linkage between S glycoprotein expression and immunopathology. Virology318:45-54. [[PubMed]
  • 261. Rest, J. S., and D. P. Mindell. 2003. SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting. Infect. Genet. Evol.3:219-225. [[PubMed]
  • 262. Resta, S., J. P. Luby, C. R. Rosenfiled, and J. D. Siegel. 1985. Isolation and propagation of a human enteric coronavirus. Science229:978-981. [[PubMed]
  • 263. Roberts, A., C. Paddock, L. Vogel, E. Butler, S. Zaki, and K. Subbarao. 2005. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J. Virol.79:5833-5838.
  • 264. Roberts, A., L. Vogel, J. Guarner, N. Hayes, B. Murphy, S. Zaki, and K. Subbarao. 2005. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J. Virol.79:503-511.
  • 265. Robitaille, J., L. Izzi, E. Daniels, B. Zelus, K. V. Holmes, and N. Beauchemin. 1999. Comparison of expression patterns and cell adhesion properties of the mouse biliary glycoproteins Bbgp1 and Bbgp2. Eur. J. Biochem.264:534-544. [[PubMed]
  • 266. Rossen, J. W., C. P. Bekker, G. J. Strous, M. C. Horzinek, G. S. Dveksler, K. V. Holmes, and P. J. Rottier. 1996. A murine and a porcine coronavirus are released from opposite surfaces of the same epithelial cells. Virology224:345-351. [[PubMed]
  • 267. Rota, P. A., M. S. Oberste, S. S. Monroe, W. A. Nix, R. Campagnoli, J. P. Icenogle, S. Penaranda, B. Bankamp, K. Maher, M. H. Chen, S. Tong, A. Tamin, L. Lowe, M. Frace, J. L. DeRisi, Q. Chen, D. Wang, D. D. Erdman, T. C. Peret, C. Burns, T. G. Ksiazek, P. E. Rollin, A. Sanchez, S. Liffick, B. Holloway, J. Limor, K. McCaustland, M. Olsen-Rasmussen, R. Fouchier, S. Gunther, A. D. Osterhaus, C. Drosten, M. A. Pallansch, L. J. Anderson, and W. J. Bellini. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science300:1394-1399. [[PubMed]
  • 268. Rowe, T., G. Gao, R. J. Hogan, R. G. Crystal, T. G. Voss, R. L. Grant, P. Bell, G. P. Kobinger, N. A. Wivel, and J. M. Wilson. 2004. Macaque model for severe acute respiratory syndrome. J. Virol.78:11401-11404.
  • 269. Saeki, K., N. Ohtsuka, and F. Taguchi. 1997. Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants. J. Virol.71:9024-9031.
  • 270. Saeki, K., N. Ohtsuka, and F. Taguchi. 1998. Isolation and characterization of murine coronavirus mutants resistant to neutralization by soluble receptors. Adv. Exp. Med. Biol.440:11-16. [[PubMed]
  • 271. Saif, LJ. 2004. Animal coronavirus vaccines: lessons for SARS. Dev. Biol.119:129-140. [[PubMed][Google Scholar]
  • 272. Saif, LJ. 2004. Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome? Rev. Sci. Technol.23:643-660. [[PubMed][Google Scholar]
  • 273. Sainz, B., Jr., E. C. Mossel, C. J. Peters, and R. F. Garry. 2004. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology329:11-17. [[PubMed]
  • 274. Sanchez, C. M., A. Izeta, J. M. Sanchez-Morgado, S. Alonso, I. Sola, M. Balasch, J. Plana-Duran, and L. Enjuanes. 1999. Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence. J. Virol.73:7607-7618.
  • 275. Sarma, J. D., E. Scheen, S. H. Seo, M. Koval, and S. R. Weiss. 2002. Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system. J. Neurovirol.8:381-391. [[PubMed]
  • 276. Scagnolari, C., E. Vicenzi, F. Bellomi, M. G. Stillitano, D. Pinna, G. Poli, M. Clementi, F. Dianzani, and G. Antonelli. 2004. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antiviral Ther.9:1003-1011. [[PubMed]
  • 277. Schelle, B., N. Karl, B. Ludewig, S. G. Siddell, and V. Thiel. 2005. Selective replication of coronavirus genomes that express nucleocapsid protein. J. Virol.79:6620-6630.
  • 278. Schultze, B., H. J. Gross, R. Brossmer, and G. Herrler. 1991. The S protein of bovine coronavirus is a hemagglutinin recognizing 9-O-acetylated sialic acid as a receptor determinant. J. Virol.65:6232-6237.
  • 279. Schultze, B., K. Wahn, H. D. Klenk, and G. Herrler. 1991. Isolated HE-protein from hemagglutinating encephalomyelitis virus and bovine coronavirus has receptor-destroying and receptor-binding activity. Virology180:221-228. [[PubMed]
  • 280. Schwarz, B., E. Routledge, and S. G. Siddell. 1990. Murine coronavirus nonstructural protein ns2 is not essential for virus replication in transformed cells. J. Virol.64:4784-4791.
  • 281. Shi, Y., H. Yang de, J. Xiong, J. Jia, B. Huang, and Y. X. Jin. 2005. Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. Cell Res.15:193-200. [[PubMed]
  • 282. Shieh, C. K., H. J. Lee, K. Yokomori, N. La Monica, S. Makino, and M. M. Lai. 1989. Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J. Virol.63:3729-3736.
  • 283. Shieh, C. K., L. Soe, S. Makino, M. F. Chang, S. A. Stohlman, and M. M. C. Lai. 1987. The 5′ end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader primed transcription. Virology156:321-330. [[PubMed]
  • 284. Simmons, G., D. N. Gosalia, A. J. Rennekamp, J. D. Reeves, S. L. Diamond, and P. Bates. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA102:11876-11881.
  • 285. Simmons, G., J. D. Reeves, A. J. Rennekamp, S. M. Amberg, A. J. Piefer, and P. Bates. 2004. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA101:4240-4245.
  • 286. Smits, S. L., G. J. Gerwig, A. L. van Vliet, A. Lissenberg, P. Briza, J. P. Kamerling, R. Vlasak, and R. J. de Groot. 2005. Nidovirus sialate-O-acetylesterases: evolution and substrate specificity of corona- and toroviral receptor-destroying enzymes. J. Biol. Chem.280:6933-6941. [[PubMed]
  • 287. Snijder, E. J., P. J. Bredenbeek, J. C. Dobbe, V. Thiel, J. Ziebuhr, L. L. Poon, Y. Guan, M. Rozanov, W. J. Spaan, and A. E. Gorbalenya. 2003. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol.331:991-1004. [[PubMed]
  • 288. Song, H. D., C. C. Tu, G. W. Zhang, S. Y. Wang, K. Zheng, L. C. Lei, Q. X. Chen, Y. W. Gao, H. Q. Zhou, H. Xiang, H. J. Zheng, S. W. Chern, F. Cheng, C. M. Pan, H. Xuan, S. J. Chen, H. M. Luo, D. H. Zhou, Y. F. Liu, J. F. He, P. Z. Qin, L. H. Li, Y. Q. Ren, W. J. Liang, Y. D. Yu, L. Anderson, M. Wang, R. H. Xu, X. W. Wu, H. Y. Zheng, J. D. Chen, G. Liang, Y. Gao, M. Liao, L. Fang, L. Y. Jiang, H. Li, F. Chen, B. Di, L. J. He, J. Y. Lin, S. Tong, X. Kong, L. Du, P. Hao, H. Tang, A. Bernini, X. J. Yu, O. Spiga, Z. M. Guo, H. Y. Pan, W. Z. He, J. C. Manuguerra, A. Fontanet, A. Danchin, N. Niccolai, Y. X. Li, C. I. Wu, and G. P. Zhao. 2005. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl. Acad. Sci. USA102:2430-2435.
  • 289. Spann, K. M., K. C. Tran, B. Chi, R. L. Rabin, and P. L. Collins. 2004. Suppression of the induction of alpha, beta, and gamma interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J. Virol.78:4363-4369.
  • 290. Sperry, S., L. Kazi, R. Graham, R. Baric, S. Weiss, and M. Denison. 2005. Single amino acid substitutions in nonstructural ORF1b-nsp14 and ORF2a 30kDa proteins of the murine coronavirus MHV-A59 are attenuating in mice. J. Virol.79:3391-3400.
  • 291. Spiegel, M., A. Pichlmair, L. Martinez-Sobrido, J. Cros, A. Garcia-Sastre, O. Haller, and F. Weber. 2005. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J. Virol.79:2079-2086.
  • 292. Stavrinides, J., and D. S. Guttman. 2004. Mosaic evolution of the severe acute respiratory syndrome coronavirus. J. Virol.78:76-82.
  • 293. Stroher, U., A. DiCaro, Y. Li, J. E. Strong, F. Aoki, F. Plummer, S. M. Jones, and H. Feldmann. 2004. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha. J. Infect. Dis.189:1164-1167. [[PubMed]
  • 294. Sturman, L. S., and K. V. Holmes. 1977. Characterization of coronavirus. II. Glycoproteins of the viral envelope: tryptic peptide analysis. Virology77:650-660. [[PubMed]
  • 295. Subbarao, K., J. McAuliffe, L. Vogel, G. Fahle, S. Fischer, K. Tatti, M. Packard, W. J. Shieh, S. Zaki, and B. Murphy. 2004. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol.78:3572-3577.
  • 296. Sugiyama, K., M. Kasai, S. Kato, H. Kasai, and K. Hatakeyama. 1998. Haemagglutinin-esterase protein (HE) of murine corona virus: DVIM (diarrhea virus of infant mice). Arch. Virol.143:1523-1534. [[PubMed]
  • 297. Sui, J., W. Li, A. Roberts, L. J. Matthews, A. Murakami, L. Vogel, S. K. Wong, K. Subbarao, M. Farzan, and W. A. Marasco. 2005. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J. Virol.79:5900-5906.
  • 298. Surjit, M., B. Liu, S. Jameel, V. T. Chow, and S. K. Lal. 2004. The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors. Biochem. J.383:13-18.
  • 299. Taguchi, F. 1995. The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J. Virol.69:7260-7263.
  • 300. Taguchi, F., P. T. Massa, and V. ter Meulen. 1986. Characterization of a variant virus isolated from neural cell culture after infection of mouse coronavirus JHMV. Virology155:267-270. [[PubMed]
  • 301. Taguchi, F., and SMatsuyama. 2002. Soluble receptor potentiates receptor-independent infection by murine coronavirus. J. Virol.76:950-958. [Google Scholar]
  • 302. Taguchi, F., and S. G. Siddell. 1985. Difference in sensitivity to interferon among mouse hepatitis viruses with high and low virulence for mice. Virology147:41-48. [[PubMed]
  • 303. Takasuka, N., H. Fujii, Y. Takahashi, M. Kasai, S. Morikawa, S. Itamura, K. Ishii, M. Sakaguchi, K. Ohnishi, M. Ohshima, S. Hashimoto, T. Odagiri, M. Tashiro, H. Yoshikura, T. Takemori, and Y. Tsunetsugu-Yokota. 2004. A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. Int. Immunol.16:1423-1430. [[PubMed]
  • 304. Talbot, P. J., and M. J. Buchmeier. 1985. Antigenic variation among murine coronaviruses: evidence for polymorphism on the pepolmer glycoprotein, E2. Virus Res.2:317-328. [[PubMed]
  • 305. Tan, Y. J., B. C. Fielding, P. Y. Goh, S. Shen, T. H. Tan, S. G. Lim, and W. Hong. 2004. Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. J. Virol.78:14043-14047.
  • 306. Tan, Y. J., E. Teng, S. Shen, T. H. Tan, P. Y. Goh, B. C. Fielding, E. E. Ooi, H. C. Tan, S. G. Lim, and W. Hong. 2004. A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis. J. Virol.78:6723-6734.
  • 307. Tang, L., Q. Zhu, E. Qin, M. Yu, Z. Ding, H. Shi, X. Cheng, C. Wang, G. Chang, F. Fang, H. Chang, S. Li, X. Zhang, X. Chen, J. Yu, J. Wang, and Z. Chen. 2004. Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice. DNA Cell Biol.23:391-394. [[PubMed]
  • 308. ter Meulen, J., A. B. Bakker, E. N. van den Brink, G. J. Weverling, B. E. Martina, B. L. Haagmans, T. Kuiken, J. de Kruif, W. Preiser, W. Spaan, H. R. Gelderblom, J. Goudsmit, and A. D. Osterhaus. 2004. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet363:2139-2141. [[PubMed]
  • 309. Thackray, L. B., and K. V. Holmes. 2004. Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59. Virology324:510-524. [[PubMed]
  • 310. Thiel, V., J. Herold, B. Schelle, and S. G. Siddell. 2001. Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J. Gen. Virol.82:1273-1281. [[PubMed]
  • 311. Thiel, V., K. A. Ivanov, A. Putics, T. Hertzig, B. Schelle, S. Bayer, B. Weissbrich, E. J. Snijder, H. Rabenau, H. W. Doerr, A. E. Gorbalenya, and J. Ziebuhr. 2003. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol.84:2305-2315. [[PubMed]
  • 312. To, K. F., P. K. Chan, K. F. Chan, W. K. Lee, W. Y. Lam, K. F. Wong, N. L. Tang, D. N. Tsang, R. Y. Sung, T. A. Buckley, J. S. Tam, and A. F. Cheng. 2001. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J. Med. Virol.63:242-246. [[PubMed]
  • 313. To, K. F., J. H. Tong, P. K. Chan, F. W. Au, S. S. Chim, K. C. Chan, J. L. Cheung, E. Y. Liu, G. M. Tse, A. W. Lo, Y. M. Lo, and H. K. Ng. 2004. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J. Pathol.202:157-163. [[PubMed]
  • 314. Traggiai, E., S. Becker, K. Subbarao, L. Kolesnikova, Y. Uematsu, M. R. Gismondo, B. R. Murphy, R. Rappuoli, and A. Lanzavecchia. 2004. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med.10:871-875. [[PubMed]
  • 315. Trifilo, M. J., C. C. Bergmann, W. A. Kuziel, and T. E. Lane. 2003. CC chemokine ligand 3 (CCL3) regulates CD8-T-cell effector function and migration following viral infection. J. Virol.77:4004-4014.
  • 316. Tsai, J. C., L. de Groot, J. D. Pinon, K. T. Iacono, J. J. Phillips, S. H. Seo, E. Lavi, and S. R. Weiss. 2003. Amino acid substitutions within the heptad repeat domain 1 of murine coronavirus spike protein restrict viral antigen spread in the central nervous system. Virology312:369-380. [[PubMed]
  • 317. Tsui, P. T., M. L. Kwok, H. Yuen, and S. T. Lai. 2003. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg. Infect. Dis.9:1064-1069.
  • 318. Tyrrel, D. A. J., J. D. Almedia, D. M. Berry, C. H. Cunningham, D. Hamre, M. S. Hofstad, L. Malluci, and K. McIntosh. 1968. Coronavirus. Nature220:650. [PubMed]
  • 319. Valarcher, J. F., J. Furze, S. Wyld, R. Cook, K. K. Conzelmann, and G. Taylor. 2004. Role of alpha/beta inerferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J. Virol.77:8426-8439.
  • 320. van der Hoek, L., K. Pyrc, M. F. Jebbink, W. Vermeulen-Oost, R. J. Berkhout, K. C. Wolthers, P. M. Wertheim-van Dillen, J. Kaandorp, J. Spaargaren, and B. Berkhout. 2004. Identification of a new human coronavirus. Nat. Med.10:368-373. [[PubMed]
  • 321. van der Hoek, L., K. Sure, G. Ihorst, A. Stang, K. Pyrc, M. F. Jebbink, G. Petersen, J. Forster, B. Berkhout, and K. Uberla. 2005. Croup is associated with the novel coronavirus NL63. PLoS Med.2:e240.
  • 322. van der Veen, RC. 1996. Immunogenicity of JHM virus proteins: characterization of a CD4+ T cell epitope on nucleocapsid protein which induces different T-helper cell subsets. Virology225:339-346. [[PubMed][Google Scholar]
  • 323. Vaughn, E. M., P. G. Halbur, and P. S. Paul. 1995. Sequence comparison of porcine respiratory coronavirus isolates reveals heterogeneity in the S, 3, and 3-1 genes. J. Virol.69:3176-3184.
  • 324. Vennema, H., G. J. Godeke, J. W. Rossen, W. F. Voorhout, M. C. Horzinek, D. J. Opstelten, and P. J. Rottier. 1996. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J.15:2020-2028.
  • 325. Vlasak, R., W. Luytjes, J. Leider, W. Spaan, and P. Palese. 1988. The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J. Virol.62:4686-4690.
  • 326. Vlasak, R., W. Luytjes, W. Spaan, and P. Palese. 1988. Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc. Natl. Acad. Sci. USA85:4526-4529.
  • 327. Wang, F. I., J. O. Fleming, and M. M. Lai. 1992. Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology186:742-749. [[PubMed]
  • 328. Wang, Z., L. Ren, X. Zhao, T. Hung, A. Meng, J. Wang, and Y. G. Chen. 2004. Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells. J. Virol.78:7523-7527.
  • 329. Wang, Z., Z. Yuan, M. Matsumoto, U. R. Hengge, and Y. F. Chang. 2005. Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice. Biochem. Biophys. Res. Commun.327:130-135. [[PubMed]
  • 330. Ward, AC. 1996. Neurovirulence of influenza A virus. J. Neurovirol.2:139-151. [[PubMed][Google Scholar]
  • 331. Weingartl, H., M. Czub, S. Czub, J. Neufeld, P. Marszal, J. Gren, G. Smith, S. Jones, R. Proulx, Y. Deschambault, E. Grudeski, A. Andonov, R. He, Y. Li, J. Copps, A. Grolla, D. Dick, J. Berry, S. Ganske, L. Manning, and J. Cao. 2004. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J. Virol.78:12672-12676.
  • 332. Weingartl, H. M., J. Copps, M. A. Drebot, P. Marszal, G. Smith, J. Gren, M. Andova, J. Pasick, P. Kitching, and M. Czub. 2004. Susceptibility of pigs and chickens to SARS coronavirus. Emerg. Infect. Dis.10:179-184.
  • 333. Weiss, S. R., P. W. Zoltick, and J. L. Leibowitz. 1993. The ns 4 gene of mouse hepatitis virus (MHV), strain A 59 contains two ORFs and thus differs from ns 4 of the JHM and S strains. Arch. Virol.129:301-309. [[PubMed]
  • 334. Wentworth, D. E., and K. V. Holmes. 2001. Addition of a single glycosylation site to hAPN blocks human coronavirus-229E receptor activity. Adv. Exp. Med. Biol.494:199-204. [[PubMed]
  • 335. Wentworth, D. E., and K. V. Holmes. 2001. Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation. J. Virol.75:9741-9752.
  • 336. Wesley, R. D., R. D. Woods, and A. K. Cheung. 1991. Genetic analysis of porcine respiratory coronavirus, an attenuated variant of transmissible gastroenteritis virus. J. Virol.65:3369-3373.
  • 337. Wilson, L., C. McKinlay, P. Gage, and G. Ewart. 2004. SARS coronavirus E protein forms cation-selective ion channels. Virology330:322-331. [[PubMed]
  • 338. Wong, R. S., A. Wu, K. F. To, N. Lee, C. W. Lam, C. K. Wong, P. K. Chan, M. H. Ng, L. M. Yu, D. S. Hui, J. S. Tam, G. Cheng, and J. J. Sung. 2003. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Br. Med. J.326:1358-1362.
  • 339. Wong, S. K., W. Li, M. J. Moore, H. Choe, and M. Farzan. 2004. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem.279:3197-3201. [[PubMed]
  • 340. Woo, P. C., S. K. Lau, C. M. Chu, K. H. Chan, H. W. Tsoi, Y. Huang, B. H. Wong, R. W. Poon, J. J. Cai, W. K. Luk, L. L. Poon, S. S. Wong, Y. Guan, J. S. Peiris, and K. Y. Yuen. 2005. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol.79:884-895.
  • 341. World Health Organization. 2003. Severe acute respiratory syndrome (SARS): multi-country outbreak. World Health Organization, Geneva, Switzerland.
  • 342. Wu, C. J., H. W. Huang, C. Y. Liu, C. F. Hong, and Y. L. Chan. 2005. Inhibition of SARS-CoV replication by siRNA. Antiviral Res.65:45-48. [[PubMed]
  • 343. Wurm, T., H. Chen, T. Hodgson, P. Britton, G. Brooks, and J. A. Hiscox. 2001. Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division. J. Virol.75:9345-9356.
  • 344. Wurzer, W. J., K. Obojes, and R. Vlasak. 2002. The sialate-4-O-acetylesterases of coronaviruses related to mouse hepatitis virus: a proposal to reorganize group 2 Coronaviridae. J. Gen. Virol.83:395-402. [[PubMed]
  • 345. Xiong, S., Y. F. Wang, M. Y. Zhang, X. J. Liu, C. H. Zhang, S. S. Liu, C. W. Qian, J. X. Li, J. H. Lu, Z. Y. Wan, H. Y. Zheng, X. G. Yan, M. J. Meng, and J. L. Fan. 2004. Immunogenicity of SARS inactivated vaccine in BALB/c mice. Immunol. Lett.95:139-143. [[PubMed]
  • 346. Xue, S., A. Jaszewski, and S. Perlman. 1995. Identification of a CD4+ T cell epitope within the M protein of a neurotropic coronavirus. Virology208:173-179. [[PubMed]
  • 347. Yang, H., M. Yang, Y. Ding, Y. Liu, Z. Lou, Z. Zhou, L. Sun, L. Mo, S. Ye, H. Pang, G. F. Gao, K. Anand, M. Bartlam, R. Hilgenfeld, and Z. Rao. 2003. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. USA100:13190-13195.
  • 348. Yang, Y., Z. Xiong, S. Zhang, Y. Yan, J. Nguyen, B. Ng, H. Lu, J. Brendese, F. Yang, H. Wang, and X. F. Yang. 2005. Bcl-xL inhibits T cell apotosis induced by expression of SARS coronavirus E protein in the absence of growth factors. Biochem. J.392:135-143.
  • 349. Yang, Z. Y., Y. Huang, L. Ganesh, K. Leung, W. P. Kong, O. Schwartz, K. Subbarao, and G. J. Nabel. 2004. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol.78:5642-5650.
  • 350. Yang, Z. Y., W. P. Kong, Y. Huang, A. Roberts, B. R. Murphy, K. Subbarao, and G. J. Nabel. 2004. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature428:561-564. [[PubMed]
  • 351. Yang, Z. Y., H. C. Werner, W. P. Kong, K. Leung, E. Traggiai, A. Lanzavecchia, and G. J. Nabel. 2005. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc. Natl. Acad. Sci. USA102:797-801.
  • 352. Yeager, C. L., R. A. Ashmun, R. K. Williams, C. B. Cardellichio, L. H. Shapiro, A. T. Look, and K. V. Holmes. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature357:420-422. [[PubMed]
  • 353. Yokomori, K., M. Asanaka, S. A. Stohlman, S. Makino, R. A. Shubin, W. Gilmore, L. P. Weiner, F. I. Wang, and M. M. Lai. 1995. Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J. Neurovirol.1:330-339. [[PubMed]
  • 354. Yokomori, K., S. C. Baker, S. A. Stohlman, and M. M. Lai. 1992. Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. J. Virol.66:2865-2874.
  • 355. Yokomori, K., L. R. Banner, and M. M. Lai. 1991. Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses. Virology183:647-657. [[PubMed]
  • 356. Yokomori, K., N. La Monica, S. Makino, C. K. Shieh, and M. M. Lai. 1989. Biosynthesis, structure, and biological activities of envelope protein gp65 of murine coronavirus. Virology173:683-691. [[PubMed]
  • 357. Yokomori, K., and M. M. Lai. 1991. Mouse hepatitis virus S RNA sequence reveals that nonstructural proteins ns4 and ns5a are not essential for murine coronavirus replication. J. Virol.65:5605-5608.
  • 358. Yokomori, K., S. A. Stohlman, and M. M. Lai. 1993. The detection and characterization of multiple hemagglutinin-esterase (HE)-defective viruses in the mouse brain during subacute demyelination induced by mouse hepatitis virus. Virology192:170-178. [[PubMed]
  • 359. Yoo, D., F. L. Graham, L. Prevec, M. D. Parker, M. Benko, T. Zamb, and L. A. Babiuk. 1992. Synthesis and processing of the haemagglutinin-esterase glycoprotein of bovine coronavirus encoded in the E3 region of adenovirus. J. Gen. Virol.73:2591-2600. [[PubMed]
  • 360. Yoshikura, H., and FTaguchi. 1978. Mouse hepatitis virus strain MHV-S: formation of pseudotypes with a murine leukemia virus envelope. Intervirology10:132-136. [[PubMed][Google Scholar]
  • 361. Youn, S., J. L. Leibowitz, and E. W. Collisson. 2005. In vitro assembled, recombinant infectious bronchitis viruses demonstrate that the 5a open reading frame is not essential for replication. Virology332:206-215. [[PubMed]
  • 362. Yount, B., K. M. Curtis, and R. S. Baric. 2000. Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model. J. Virol.74:10600-10611.
  • 363. Yount, B., K. M. Curtis, E. A. Fritz, L. E. Hensley, P. B. Jahrling, E. Prentice, M. R. Denison, T. W. Geisbert, and R. S. Baric. 2003. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA100:12995-13000.
  • 364. Yount, B., M. R. Denison, S. R. Weiss, and R. S. Baric. 2002. Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J. Virol.76:11065-11078.
  • 365. Yu, X., W. Bi, S. R. Weiss, and J. L. Leibowitz. 1994. Mouse hepatitis virus gene 5b protein is a new virion envelope protein. Virology202:1018-1023. [[PubMed]
  • 366. Yuan, X., Y. Shan, Z. Zhao, J. Chen, and Y. Cong. 2005. G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells. Virol. J.2:66.
  • 367. Zakhartchouk, A. N., Q. Liu, M. Petric, and L. A. Babiuk. 2005. Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines. Vaccine23:4385-4391. [[PubMed]
  • 368. Zakhartchouk, A. N., S. Viswanathan, J. B. Mahony, J. Gauldie, and L. A. Babiuk. 2005. Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice. J. Gen. Virol.86:211-215. [[PubMed]
  • 369. Zelus, B. D., J. H. Schickli, D. M. Blau, S. R. Weiss, and K. V. Holmes. 2003. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37°C either by soluble murine CEACAM1 receptors or by pH 8. J. Virol.77:830-840.
  • 370. Zeng, F., K. Y. Chow, C. C. Hon, K. M. Law, C. W. Yip, K. H. Chan, J. S. Peiris, and F. C. Leung. 2004. Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments. Biochem. Biophys. Res. Commun.315:1134-1139. [[PubMed]
  • 371. Zhang, X. W., Y. L. Yap, and A. Danchin. 2005. Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus. Arch. Virol.150:1-20. [[PubMed]
  • 372. Zhao, P., J. Cao, L. J. Zhao, Z. L. Qin, J. S. Ke, W. Pan, H. Ren, J. G. Yu, and Z. T. Qi. 2005. Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine. Virology331:128-135. [[PubMed]
  • 373. Zheng, B., M. L. He, K. L. Wong, C. T. Lum, L. L. Poon, Y. Peng, Y. Guan, M. C. Lin, and H. F. Kung. 2004. Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). J. Interferon Cytokine Res.24:388-390. [[PubMed]
  • 374. Zheng, B. J., Y. Guan, Q. Tang, C. Du, F. Y. Xie, M. L. He, K. W. Chan, K. L. Wong, E. Lader, M. C. Woodle, P. Y. Lu, B. Li, and N. Zhong. 2004. Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus. Antiviral Ther.9:365-374. [[PubMed]
  • 375. Zhong, N. S., B. J. Zheng, Y. M. Li, Poon, Z. H. Xie, K. H. Chan, P. H. Li, S. Y. Tan, Q. Chang, J. P. Xie, X. Q. Liu, J. Xu, D. X. Li, K. Y. Yuen, Peiris, and Y. Guan. 2003. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet362:1353-1358. [[PubMed]
  • 376. Zhou, J., W. Wang, Q. Zhong, W. Hou, Z. Yang, S. Y. Xiao, R. Zhu, Z. Tang, Y. Wang, Q. Xian, H. Tang, and L. Wen. 2005. Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys. Vaccine23:3202-3209. [[PubMed]
  • 377. Zhu, M. S., Y. Pan, H. Q. Chen, Y. Shen, X. C. Wang, Y. J. Sun, and K. H. Tao. 2004. Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine. Immunol. Lett.92:237-243. [[PubMed]
  • 378. Ziebuhr, J. 2005. The coronavirus replicase. Curr. Top. Microbiol. Immunol.287:57-94. [[PubMed]
  • 379. Ziebuhr, J., V. Thiel, and A. E. Gorbalenya. 2001. The autocatalytic release of a putative RNA virus transcription factor from its polyprotein precursor involves two paralogous papain-like proteases that cleave the same peptide bond. J. Biol. Chem.276:33220-33232. [[PubMed]
  • 380. Zuckerman, A. J., P. E. Taylor, and D. Almeida. 1970. Presence of particles other than the Australia-SH antigen in a case of active hepatitis with cirrhosis. Br. Med. J.1:262-264.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.